ClinicalTrials.gg
Not yet recruitingNCT07657533RCTUpdated Jun 18, 2026

Comparative Effectiveness of Different Neural Mobilization Techniques in Plantar Fasciitis

An interventional study of nerve mobilization and physical therapy in Plantar Fasciitis, Chronic, sponsored by Prince Sattam Bin Abdulaziz University. Not yet recruiting at 1 site in Saudi Arabia. Open to participants aged 18 Years to 50 Years. Per ClinicalTrials.gov, last updated 2026-06-18.

Sponsored by Prince Sattam Bin Abdulaziz University · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
60
Allocation
Randomized
Ages
18 Years to 50 Years
Sex
All
01

Study summary

BThis study will be designed to compare between the effect of adding posterior tibial nerve or saphenous nerve mobilization to the traditional physical therapy on pain intensity, foot function, pressure pain threshold, ankle dorsiflexion ROM and central sensitization in patients with PF.

Read the detailed description

: Sixty patients with PF will be included in this study: Patients will be randomly assigned into three groups. Patients in group A will receive traditional physical therapy plus posterior tibial nerve mobilization while group B will receive the same traditional physical therapy and saphenous nerve mobilization, and group C will receive only traditional physical therapy. Three sessions will be held for six weeks. Patients will be evaluated for pain intensity, pressure pain threshold (PPT), foot function, ankle dorsiflexion ROM and central sensitization

02

Conditions studied

  • Plantar Fasciitis, Chronic

Browse trials for

Keywords

  • plantar fasciopathy
  • neural mobilization
  • conventional therapy
  • central sensitization
03

In context

Fasciitis, Plantar

223 studies on the registry are indexed under Fasciitis, Plantar; 58 are open to participants now.

This study's planned enrollment of 60 is close to the median of 56 across 194 interventional studies indexed under Fasciitis, Plantar.

Browse Fasciitis, Plantar studies →

Lead sponsor

Prince Sattam Bin Abdulaziz University is the lead sponsor of 35 studies on the registry; 9 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 50 Years
Sexes eligible
All
Accepts healthy volunteers
No

Eligibility criteria

Inclusion Criteria:

  • Anyone between the ages of 18 and 50
  • plantar heel pain for six weeks or more was eligible to participate.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Investigator, Outcomes assessor)
Enrollment
60 participants (estimated)

Study arms

  • Experimental
    posterior tibial nerve group

    neural mobilization for podterior tibial nerve

    Other: nerve mobilization · Other: physical therapy

  • Experimental
    saphnous nerve group

    neural mobilization for saphenous nerve

    Other: physical therapy · Other: saphenous nerve mobilization

  • Active comparator
    Control group

    conventional therapy

    Other: physical therapy

Interventions

  • Othernerve mobilization

    posterior tibial and saphenous nerve mobilization

  • Otherphysical therapy

    stretching of plantar fascia

  • Othersaphenous nerve mobilization

    saphenous nerve mobilization

06

What researchers measure

Primary outcomes

  1. pressure pain threshold

    the lowest pressure at which pain is felt, was measured using a pressure algometer

    Time frame: pre and after six weeks

  2. central sensitization

    measuring CSI by the arabic version of CSI

    Time frame: Pre and after six weeks

Secondary outcomes

  1. ankle ROM

    measuring ROM BY GONIOMETR

    Time frame: Pre and after six weeks

07

Study locations

1 site
08

References and documents

Publications

  • Basson A, Olivier B, Ellis R, Coppieters M, Stewart A, Mudzi W. The Effectiveness of Neural Mobilization for Neuromusculoskeletal Conditions: A Systematic Review and Meta-analysis. J Orthop Sports Phys Ther. 2017 Sep;47(9):593-615. doi: 10.2519/jospt.2017.7117. Epub 2017 Jul 13. PubMed 28704626 ↗
  • Plaza-Manzano G, Rios-Leon M, Martin-Casas P, Arendt-Nielsen L, Fernandez-de-Las-Penas C, Ortega-Santiago R. Widespread Pressure Pain Hypersensitivity in Musculoskeletal and Nerve Trunk Areas as a Sign of Altered Nociceptive Processing in Unilateral Plantar Heel Pain. J Pain. 2019 Jan;20(1):60-67. doi: 10.1016/j.jpain.2018.08.001. Epub 2018 Aug 16. PubMed 30121357 ↗

Individual participant data

Plan to share: Undecided

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Jul 2026; primary completion for Sep 2026, 2 months later.

Of 104 non-industry interventional studies with no phase under Fasciitis, Plantar, half reached primary completion within 11 months of starting (the median), counting those still running; a quarter within 6 and three quarters within 21. This study's planned 2 months is below that.

Counting every sponsor, half of 109 studies reached it within 11 months; a quarter within 6 and three quarters within 22.

How these figures are worked out, and which studies are left out of them.

Registered
Jun 14, 2026
First posted
Jun 18, 2026
StartEst.
Jul 1, 2026
Primary completionEst.
Sep 1, 2026
CompletionEst.
Oct 1, 2026
Last update
Jun 18, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jun 18, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07657533
Lead sponsor
Prince Sattam Bin Abdulaziz University
Responsible party
Mohammad Moustafa Aldosoukki Hegazy (ASSISSTANT PROFESSOR, Prince Sattam Bin Abdulaziz University) — Principal investigator
First posted
Jun 18, 2026
Start date
Jul 1, 2026 (estimated)
Primary completion
Sep 1, 2026 (estimated)
Completion
Oct 1, 2026 (estimated)
Last update
Jun 18, 2026

Study contacts

Mohammed Hegazy
Contact
m.hegazy@psau.edu.sa
+966566169893

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Jun 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion